Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma.

[1]  Jacques Estève,et al.  Trends in cancer incidence and mortality. , 2009 .

[2]  G. Fioretta,et al.  Determinants of long term survival after surgery for cancer of the lung , 1999, Cancer.

[3]  M. Licker,et al.  Time trend in the surgical management of patients with lung carcinoma. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[4]  C. Emond,et al.  Lung cancer in women compared with men: stage, treatment, and survival. , 1998, The Annals of thoracic surgery.

[5]  M. Janssen-Heijnen.  Trends in lung cancer incidence and survival: studies based on cancer registries , 1998 .

[6]  M. Socinski,et al.  Estrogen‐receptor‐related protein p29 in primary nonsmall cell lung carcinoma , 1998 .

[7]  M. Bovenzi,et al.  Cigarette smoking and histologic type of lung cancer in men. , 1997, Chest.

[8]  P. Musiani,et al.  Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancer. , 1997, American journal of respiratory cell and molecular biology.

[9]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[10]  J. Roth,et al.  Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol , 1997, Oncogene.

[11]  R. Chlebowski,et al.  Gender influence on weight‐loss pattern and survival of nonsmall cell lung carcinoma patients , 1996, Cancer.

[12]  M Paesmans,et al.  Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  R. Mentzer,et al.  Sex hormone receptors in non-small-cell lung cancer in human beings. , 1994, The Journal of thoracic and cardiovascular surgery.

[14]  E. Wynder,et al.  Re: Endocrine factors and adenocarcinoma of the lung in women. , 1994, Journal of the National Cancer Institute.

[15]  Michael S. Pepper,et al.  The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth , 1994, Nature.

[16]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[17]  P. Cagle,et al.  Estrogen and progesterone receptors in bronchogenic carcinoma. , 1990, Cancer research.

[18]  H. Golomb,et al.  Sex-associated differences in presentation and survival in patients with lung cancer. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  K. Sugimachi,et al.  Longer survival after resection of non-small cell lung cancer in Japanese women. , 1989, The Annals of thoracic surgery.

[20]  S. Steinberg,et al.  Female patients with small cell lung cancer live longer than male patients. , 1988, The American journal of medicine.

[21]  J. Fraumeni,et al.  Lung cancer among Chinese women , 1987, International journal of cancer.

[22]  C. Beattie,et al.  Steroid receptors in human lung cancer. , 1985, Cancer research.

[23]  C. Beattie,et al.  Steroid receptors in human lung cancer cytosols. , 1982, Cancer letters.

[24]  W. E. Miller,et al.  Radiographic abnormalities in carcinoma of the lung as related to histological cell type. , 1969, Thorax.

[25]  N. Breslow,et al.  Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .

[26]  D. Cox.  Regression Models and Life-Tables , 1972 .

[27]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.